Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECK Cocktail for Postoperative Pain in Posterior Spinal Fusion
NCT06447194Phase 2Withdrawn
- Sponsor
- University of Maryland, Baltimore
- Start
- Oct 2025
- Primary completion
- Jan 2027
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised trial of ropivacaine, epinephrine, clonidine and ketorolac in postoperative pain (2 arms), sponsored by University of Maryland, Baltimore. Primary endpoint: Visual Analog Scale Pain Score at 4 days. Planned start Oct 2025; status: withdrawn.
02
Drugs
ropivacaineepinephrineclonidineketorolac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06447194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06447194.